These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12729993)

  • 21. Comparison of the Etest and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species.
    Meletiadis J; Mouton JW; Meis JF; Bouman BA; Verweij PE
    J Clin Microbiol; 2002 Aug; 40(8):2876-85. PubMed ID: 12149345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Etest performed in Mueller-Hinton agar supplemented with glucose for antifungal susceptibility testing of clinical isolates of filamentous fungi.
    Pinto E; Lago M; Branco L; Vale-Silva LA; Pinheiro MD
    Mycopathologia; 2014 Apr; 177(3-4):157-66. PubMed ID: 24570038
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.
    Martín-Mazuelos E; Pemán J; Valverde A; Chaves M; Serrano MC; Cantón E
    J Antimicrob Chemother; 2003 Sep; 52(3):365-70. PubMed ID: 12917236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of fatty acid RPMI 1640 media for testing susceptibilities of eight Malassezia species to the new triazole posaconazole and to six established antifungal agents by a modified NCCLS M27-A2 microdilution method and Etest.
    Velegraki A; Alexopoulos EC; Kritikou S; Gaitanis G
    J Clin Microbiol; 2004 Aug; 42(8):3589-93. PubMed ID: 15297502
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method.
    Gehrt A; Peter J; Pizzo PA; Walsh TJ
    J Clin Microbiol; 1995 May; 33(5):1302-7. PubMed ID: 7615745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of assessment of oxygen consumption, Etest, and CLSI M38-A2 broth microdilution methods for evaluation of the susceptibility of Aspergillus fumigatus to posaconazole.
    Araujo R; Espinel-Ingroff A
    Antimicrob Agents Chemother; 2009 Nov; 53(11):4921-3. PubMed ID: 19704132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility of filamentous fungi to voriconazole tested by two microdilution methods.
    Linares MJ; Charriel G; Solís F; Rodriguez F; Ibarra A; Casal M
    J Clin Microbiol; 2005 Jan; 43(1):250-3. PubMed ID: 15634979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of disk diffusion method for determining posaconazole susceptibility of filamentous fungi: comparison with CLSI broth microdilution method.
    López-Oviedo E; Aller AI; Martín C; Castro C; Ramirez M; Pemán JM; Cantón E; Almeida C; Martín-Mazuelos E
    Antimicrob Agents Chemother; 2006 Mar; 50(3):1108-11. PubMed ID: 16495281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years.
    Pfaller MA; Carvalhaes CG; Messer SA; Rhomberg PR; Castanheira M
    Diagn Microbiol Infect Dis; 2021 Nov; 101(3):115473. PubMed ID: 34352433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activity of BAL 4815 against filamentous fungi.
    Martín de la Escalera C; Aller AI; López-Oviedo E; Romero A; Martos AI; Cantón E; Pemán J; García Martos P; Martín-Mazuelos E
    J Antimicrob Chemother; 2008 May; 61(5):1083-6. PubMed ID: 18326856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
    Shi JY; Xu YC; Shi Y; Lü HX; Liu Y; Zhao WS; Chen DM; Xi LY; Zhou X; Wang H; Guo LN
    Chin Med J (Engl); 2010 Oct; 123(19):2706-9. PubMed ID: 21034656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the EUCAST-AFST broth dilution method with the CLSI reference broth dilution method (M38-A) for susceptibility testing of posaconazole and voriconazole against Aspergillus spp.
    Chryssanthou E; Cuenca-Estrella M
    Clin Microbiol Infect; 2006 Sep; 12(9):901-4. PubMed ID: 16882296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicenter evaluation of a new disk agar diffusion method for susceptibility testing of filamentous fungi with voriconazole, posaconazole, itraconazole, amphotericin B, and caspofungin.
    Espinel-Ingroff A; Arthington-Skaggs B; Iqbal N; Ellis D; Pfaller MA; Messer S; Rinaldi M; Fothergill A; Gibbs DL; Wang A
    J Clin Microbiol; 2007 Jun; 45(6):1811-20. PubMed ID: 17428932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds.
    Szekely A; Johnson EM; Warnock DW
    J Clin Microbiol; 1999 May; 37(5):1480-3. PubMed ID: 10203509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison study of broth macrodilution and microdilution antifungal susceptibility tests for the filamentous fungi.
    Pujol I; Guarro J; Llop C; Soler L; Fernández-Ballart J
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2106-10. PubMed ID: 8878589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative in vitro activities of posaconazole, voriconazole, itraconazole, and amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus.
    Arikan S; Sancak B; Alp S; Hascelik G; McNicholas P
    Med Mycol; 2008 Sep; 46(6):567-73. PubMed ID: 19180726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Identification of filamentous fungi isolated from clinical samples by two different methods and their susceptibility results].
    Direkel S; Otağ F; Aslan G; Ulger M; Emekdaş G
    Mikrobiyol Bul; 2012 Jan; 46(1):65-78. PubMed ID: 22399173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of terbinafine against medically important non-dermatophyte species of filamentous fungi.
    Garcia-Effron G; Gomez-Lopez A; Mellado E; Monzon A; Rodriguez-Tudela JL; Cuenca-Estrella M
    J Antimicrob Chemother; 2004 Jun; 53(6):1086-9. PubMed ID: 15102749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
    Cuenca-Estrella M; Gomez-Lopez A; Mellado E; Buitrago MJ; Monzon A; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2006 Mar; 50(3):917-21. PubMed ID: 16495251
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Sun L; Wan Z; Li R; Yu J
    J Med Microbiol; 2019 Nov; 68(11):1664-1670. PubMed ID: 31553302
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.